| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | CN1178537A Anti-TPO monoclonal antibody |
| 04/08/1998 | CN1178472A Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 04/08/1998 | CN1178242A Specific antibody Anti 5-7 for pseudohypertrophic muscular dystrophy |
| 04/07/1998 | US5736512 First ligation substrate comprising atleast one amino acid residue having its carboxy group terminated with 2-hydroxy carboxylic acid capable of binidng serine protease variant and catalytically reacting with second substrate |
| 04/07/1998 | US5736510 Antibiotics 10381v, w, x,y, z1, z2, pre-b and t |
| 04/07/1998 | US5736400 Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736390 BCRF1 proteins as inhibitors of interferon-γ |
| 04/07/1998 | US5736389 Treatment of colorectal cancer |
| 04/07/1998 | US5736379 DNA sequences expressing mammalian α1 antitrypsin |
| 04/07/1998 | US5736361 Production of gonorrheal PI proteins |
| 04/07/1998 | US5736347 Nucleic acids of Rochalimaea henselae and methods and compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infection |
| 04/07/1998 | US5736341 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736315 Methods and compositions for detecting anti-hepatitis E virus activity |
| 04/07/1998 | US5736149 Allergenic proteins and peptides from johnson grass pollen |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | CA1339800C Process for recovering polypeptides localized in the periplasmic space of yeast |
| 04/07/1998 | CA1339798C Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 04/02/1998 | WO1998013505A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | WO1998013501A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | WO1998013498A1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013388A1 Antibody against human parathormone related peptides |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013070A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998012913A1 Expression of globin proteins in plants |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | CA2266626A1 Expression of globin proteins in plants |
| 04/02/1998 | CA2266619A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | CA2265554A1 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | CA2265519A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/01/1998 | EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832976A2 Thermostable DNA polymerase from bacillus pallidus |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832972A2 Cloning, expression and production of tasty peptides |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832268A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 04/01/1998 | EP0832267A1 Adenovirus vectors for gene therapy |
| 04/01/1998 | EP0832253A2 Nucleic acid respiratory syncytial virus vaccines |
| 04/01/1998 | EP0832252A1 Use of gram-positive bacteria to express recombinant proteins |
| 04/01/1998 | EP0832251A1 Human ice homolog |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832245A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |
| 04/01/1998 | EP0832235A1 HIGH METHIONINE DERIVATIVES OF alfa-HORDOTHIONIN |
| 04/01/1998 | EP0832232A1 Kunitz type plasma kallikrein inhibitors |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832229A2 Cd40l mutein |
| 04/01/1998 | EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 04/01/1998 | EP0832226A2 Ebnerin cloning of a secreted von ebner's gland protein |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832221A1 Bone stimulating factor |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832217A1 Modified steroid hormones for gene therapy and methods for their use |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832209A1 Secretion leader trap cloning method |
| 04/01/1998 | EP0832207A1 A method for identification of biologically active peptides and nucleic acids |
| 04/01/1998 | EP0832199A1 Fucosyltransferase genes and uses thereof |
| 04/01/1998 | EP0832191A1 Recombinant viral nucleic acids |
| 04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 04/01/1998 | EP0832185A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
| 04/01/1998 | EP0832128A2 Thrombin receptor homolog |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832121A1 Methods for purifying authentic igf from yeast hosts |
| 04/01/1998 | EP0832118A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 04/01/1998 | EP0832116A1 New dna molecules |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832108A1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/01/1998 | EP0832098A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 04/01/1998 | EP0832093A1 Expression of lipoproteins |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells |
| 04/01/1998 | EP0831906A1 Treatment of t cell mediated autoimmune disorders |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |